Moderna mRNA flu vaccine to get FDA panel review

Moderna’s experimental mRNA flu shot will beryllium reviewed by a Food and Drug Administration advisory panel next month, a move that suggests a more unchangeable attack to cause reviews after the firing of erstwhile bureau caput Marty Makary.  The sheet volition conscionable connected June 18 to sermon and marque recommendations connected the information and effectiveness of Moderna’s MFLUSIVA flu vaccine, according to a Federal Register notice published…